Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 23, 2024British Journal of Haematology

Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS‐SFB31

View Full Paper
Ask AI
Bookmark
Share

Authors

LLLinlin LiuBLBing LiZXZefeng Xu

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e6e098b6db64358765c2bfhttps://doi.org/10.1111/bjh.19482
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or SF3B1 Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review2024 · 7 citations
  2. 2Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases2024 · 1 citations
  3. 3Clinico‐genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification2023 · 15 citations
  4. 4Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms2024 · 29 citations
  5. 5Reclassification of Myelodysplastic Neoplasms According to the 2022 World Health Organization Classification and the 2022 International Consensus Classification Using Open-Source Data: Focus on <i>SF3B1-</i> and <i>TP53</i>-mutated Myelodysplastic Neoplasms2024